Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma

Endocrine-Related Cancer

Volumn 15, Issue 3, 2008, Pages 777-786

  Margetts, Caroline D E ^a   Morris, Mark ^a   Astuti, Dewi ^a   Gentle, Dean C ^a   Cascon, Alberto ^b   McRonald, Fiona E ^a   Catchpoole, Daniel ^c   Robledo, Mercedes ^b   Neumann, Hartmut P H ^d   Latif, Farida ^a   Maher, Eamonn R ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; ADENYLATE KINASE 1; AZACITIDINE; CYSTATIN E; CYSTATIN M; CYTOKERATIN 19; EPITHELIAL MEMBRANE PROTEIN 3; GENE PRODUCT; HEAT SHOCK PROTEIN 47; HOMEOBOX A9; JUNCTION PLAKOGLOBIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 3; OPIATE BINDING PROTEIN; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE 2 BETA; SMOOTHELIN; STANNIN; TRANSCRIPTION FACTOR AP 4; TRIPARTITE MOTIF PROTEIN 3; TRISTETRAPROLIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DNA MICROARRAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC EPIGENESIS; HUMAN; HUMAN CELL; MOLECULAR GENETICS; NEUROBLASTOMA; NEUROBLASTOMA CELL; PHEOCHROMOCYTOMA; PROMOTER REGION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ADRENAL GLAND NEOPLASMS; ADULT; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HUMANS; NEURAL CREST; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHEOCHROMOCYTOMA; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 53849146718     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0072     Document Type: Article

References (38)

1. Alaminos M, Davalos V, Cheung NK, Gerald WL & Esteller M 2004 Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. Journal of the National Cancer Institute 96 1208-1219.
2. Alaminos M, Davalos V, Ropero S, Setien F, Paz MF, Herranz M, Fraga MF, Mora J, Cheung NK, Gerald WL et al. 2005 EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Research 65 2565-2571.
3. Amitay R, Nass D, Meitar D, Goldberg I, Davidson B, Trakhtenbrot L, Brok-Simom F, Ben-Ze'ev A, Rechavi G & Kaufmann Y 2001 Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma. American Journal of Pathology 159 43-49.
4. Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay K, Buckley J, Ortega A & Seeger RC 2006 Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. Journal of the National Cancer Institute 98 1193-1203.
5. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C & Maher ER 2001a Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics 69 49-54.
6. Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG, Eng C, Latif F & Maher ER 2001b Germline SDHD mutation in familial phaeochromocytoma. Lancet 357 1181-1182.
7. Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P et al. 2001c RASSFIA promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 20 7573-7577.
8. Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont A et al. 2003 Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Journal of Clinical Endocrinology, 59 728-733.
9. Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR & Dahiya R 2005 Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Clinical Cancer Research 11 557-564.
10. Chrisoulidou A, Kaltsas G, Ilias I & Grossman AB 2007 The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocrine-Related Cancer 14 569-585.
11. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST & Vertino PM 2000 TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Research 60 6236-6242.
12. Disick GI & Palese MA 2007 Extra-adrenal pheochromocytoma: diagnosis and management. Current Urology Reports 8 83-88.
13. Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PL, O'Riordan JL & Toledo SP 1995 Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. Journal of Medical Genetics 32 934-937.
14. George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, Diller L, Fortina P et al. 2007 Genome-wide analysis of neurobtastomas using high-density single nucleotide polymorphism arrays. PLoS ONE 2 e255.
15. Gimenez-Roqueplo AP 2006 New advances in the genetics of pheochromocytoma and paraganglioma syndromes. Annals of the New York Academy of Sciences 1073 112-121.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD & Baylin SB 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. PNAS 93 9821-9826.
17. Hofstra RM, Cheng NC, Hansen C, Stulp RP, Stelwagen T, Clausen N, Tommerup N, Caron H, Westerveld A, Versteeg R et al. 1996 No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma. Human Genetics 97 362-364.
18. Lind GE, Skotheim RI, Fraga MF, Abeler VM, Esteller M & Lothe RA 2006 Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). Journal of Pathology 210 441-449.
19. Liu WJ, Wang L, Wang JP, Li JQ, Zhang CO, Zheng L & Yuan YF 2006 Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma. Ai Zheng 25 696-700.
20. Lodygin D, Epanchintsev A, Menssen A, Diebold J & Hermeking H 2005 Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Research 65 4218-4227.
21. Margetts CDE, Astuti D, Gentle DC, Cooper WN, Cascon A, Catchpoole D. Robledo M, Neumann HPH, Latif F & Maher ER 2005 Epigenetic analysis of HIC 1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocrine-Related Cancer 12 161-172.
22. Morris MR, Gentle DC, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, The B et al. 2005 Tumour suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Research 65 4598-4606.
23. Morris MR, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, The BT, Latif F & Maher ER 2008 Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. British Journal of Cancer 98 496-501.
24. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466.
25. Okuda H, Toyota M, Ishida W, Furihata M, Tsuchiya M, Kamada M, Tokino T & Shuin T 2006 Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma. Oncogene 25 1733-1742.
26. Piotrowski A, Benetkiewicz M, Menzel U, de Ståhl TD, Mantripragada K, Grigelionis G, Buckley P, Jankowski M, Hoffman J, Bala D et al. 2006 Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer. Genes, Chromosomes and Cancer 45 656-667.
27. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, Lau SK, Kernstine KH, Riggs AD & Pfeifer GP 2007 Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. PNAS 104 5527-5532.
28. Reed JE, Dunn JR, Du Plessis DG, Shaw EJ, Reeves P, Gee AL, Warnke PC, Sellar GC, Moss DJ & Walker C 2007 Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours. Neuropathology and Applied Neurobiology 33 77-85.
29. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH & Goggins M 2003 Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Research 63 3735-3742.
30. Sauk JJ, Nikitakis N & Slavash H 2005 Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target. Frontiers in Bioscience 10 107-118.
31. Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, Massie CE, Miller J, Contreras-Moreira B, Scott D et al. 2003 OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nature Genetics 34 337-343.
32. Sun HY, Cui B, Su DW, Jin XL, Sun FK, Zu Y, Jiang L, Wang WQ & Ning G 2006 LOH on chromosome 11q, but not SDHD and Men1 mutations was frequently detectable in Chinese patients with pheochromocytoma and paraganglioma. Endocrine 30 307-312.
33. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D et al. 2006 CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genetics 38 787-793.
34. Wilson I, Davies J, Weber M, Brown C, Alvarez CE, MacAulay C, Schübeler D & Lam WL 2006 Epigenomics: mapping the methylome. Cell Cycle 5 155-158.
35. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ & Sidransky D 2002 Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2 485-495.
36. Yang Q, Liu S, Tian Y, Hasan C, Kersey D, Salwen HR, Chlenski A, Perlman EJ & Cohn SL 2004 Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Research 64 4531-4538.
37. Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB & Cohn SL 2007 Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clinical Cancer Research 13 3191-3197.
38. Yokogoshi Y, Yoshimoto K & Saito S 1990 Loss of heterozygosity on chromosomes 1 and 11 in sporadic pheochromocytomas. Japanese Journal of Cancer Research 81 632-638.